Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 13, 2023

SELL
$6.71 - $11.83 $30,624 - $53,992
-4,564 Reduced 33.65%
9,001 $61,000
Q2 2023

Aug 21, 2023

BUY
$11.12 - $22.2 $8,028 - $16,028
722 Added 5.62%
13,565 $156,000
Q3 2022

Nov 22, 2022

SELL
$16.98 - $25.54 $45,115 - $67,859
-2,657 Reduced 17.14%
12,843 $241,000
Q3 2021

Nov 10, 2021

BUY
$26.01 - $38.22 $403,155 - $592,410
15,500 New
15,500 $496,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.